Identification of G4-regulated immune-related drug targets for prostate cancer based on G4 screen and machine learning.

Ge L, Hou Y, Huang X, Zhang J, Yao L, Chen S, Mao L, Ning W, Liang H, Shi N, Yang C, Jiang D, Shen Y, Zheng B, Shu C, Zhang M

Open source

DOI: 10.3389/fimmu.2026.1806289
Published: 2026
Container: Frontiers in immunology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fimmu.2026.1806289,
  title = {Identification of G4-regulated immune-related drug targets for prostate cancer based on G4 screen and machine learning.},
  author = {Ge L and Hou Y and Huang X and Zhang J and Yao L and Chen S and Mao L and Ning W and Liang H and Shi N and Yang C and Jiang D and Shen Y and Zheng B and Shu C and Zhang M},
  year = {2026},
  journal = {Frontiers in immunology},
  doi = {10.3389/fimmu.2026.1806289},
  url = {https://doi.org/10.3389/fimmu.2026.1806289}
}

RIS

TY  - JOUR
TI  - Identification of G4-regulated immune-related drug targets for prostate cancer based on G4 screen and machine learning.
AU  - Ge L
AU  - Hou Y
AU  - Huang X
AU  - Zhang J
AU  - Yao L
AU  - Chen S
AU  - Mao L
AU  - Ning W
AU  - Liang H
AU  - Shi N
AU  - Yang C
AU  - Jiang D
AU  - Shen Y
AU  - Zheng B
AU  - Shu C
AU  - Zhang M
PY  - 2026
JO  - Frontiers in immunology
DO  - 10.3389/fimmu.2026.1806289
UR  - https://doi.org/10.3389/fimmu.2026.1806289
ER  -

APA

L, G., Y, H., X, H., J, Z., L, Y., S, C., L, M., W, N., H, L., N, S., C, Y., D, J., Y, S., B, Z., C, S., & M, Z. (2026). Identification of G4-regulated immune-related drug targets for prostate cancer based on G4 screen and machine learning.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1806289

Source records

pubmed · retrieved 2026-09-25T10:48:26.735Z